New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and ...
Pacientes que tomaram medicamentos para distúrbios de movimento, como a síndrome das pernas inquietas, dizem que seu ...
Cepa H5N1 tem se disseminado de forma inédita entre populações de mamíferos, como no gado leiteiro dos EUA, e acumulado ...
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced new data from two implementation studies showing zero cases of HIV ...
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced new data from two implementation studies showing zero cases of HIV ...
Os cookies funcionais ajudam a realizar certas funcionalidades, como compartilhar o conteúdo do site em plataformas de mídia social, coletar feedback e outras funcionalidades de terceiros.
The latest research report published by Vantage Market Research, titled "An Increase in Demand and Opportunities for the ...
GSK to showcase latest research at the International RSV Symposium to advance RSV prevention in adults: London, UK Saturday, March 8, 2025, 14:00 Hrs [IST] GSK plc will share its ...
A majority of Indians who have the virus causing shingles, a painful age-related disease, are unaware of it. As per the ...
Clean200 companies generated $2.5 trillion, reducing fossil fuel reliance while growing sustainable revenues twice as fast.
LONDON, - British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale back or abandon such goals in response to the U.S. president's ...
LONDON - GSK plc, the global healthcare company, has released its Annual Report for the fiscal year ending December 31, 2024. The report was published on the company's website today and is also set to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback